Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|June 17, 2004
[Primary malignant lymphoma of the urinary bladder: a case report]Hidekazu Koike, Takahiro Morita, Yoshimi Tamura
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 22, 2007
Remnant lipoproteins stimulate proliferation and activate MAPK and Akt signaling pathways via G protein-coupled receptor in PC-3 prostate cancer cellsYoshitaka Sekine, Hidekazu Koike, Takamitsu Nakano, et al.
The Journal of Urology|February 22, 2011
Survivin is associated with cell proliferation and has a role in 1a,25-dihydroxyvitamin D3 induced cell growth inhibition in prostate cancerHidekazu Koike, Yasuyuki Morikawa, Yoshitaka Sekine, et al.
Biochemical and Biophysical Research Communications|May 21, 2008
Simvastatin inhibits the proliferation of human prostate cancer PC-3 cells via down-regulation of the insulin-like growth factor 1 receptorYoshitaka Sekine, Yosuke Furuya, Masahiro Nishii, et al.
Prostate International|July 1, 2016
Low-density lipoprotein receptors play an important role in the inhibition of prostate cancer cell proliferation by statinsYosuke Furuya, Yoshitaka Sekine, Haruo Kato, et al.
Cancer Letters|October 22, 2003
Regulation of metallothionein and zinc transporter expression in human prostate cancer cells and tissuesMasaru Hasumi, Kazuhiro Suzuki, Hiroshi Matsui, et al.
Cancer Epidemiology|August 15, 2009
Remnant lipoproteins induced proliferation of human prostate cancer cell, PC-3 but not LNCaP, via low density lipoprotein receptorYoshitaka Sekine, Hidekazu Koike, Takamitsu Nakano, et al.
Pageof 9